Parallax Volatility Advisers, L.P. Vaxcyte, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$46.0 - $53.1 $1.38 Million - $1.59 Million	30,000 New	30,000 $1.53 Million
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $205,799 - $479,500	10,000 Added 72.99%	23,700 $1.14 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $297,153 - $390,861	13,700 New	13,700 $328,000

352

122M

775K

433K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.1B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.